Metabolic disorders of acute exposure to malathion in adult Wistar rats

Journal of Hazardous Materials

Volumn 163, Issue 2-3, 2009, Pages 1052-1055

  Lasram, Mohamed M ^a   Annabi, Alya Berrahal ^a   Elj, Naziha El ^a   Selmi, Slimen ^a   Kamoun, Abdelaziz ^a   El Fazaa, Saloua ^a   Gharbi, Najoua ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

Author keywords

Cholesterol; HDL; Hyperglycaemia; LDL; Malathion; Triglyceride

Indexed keywords

CHOLESTEROL; DISEASES; INSECTICIDES; RATS; VEGETABLE OILS;

CARDIO-VASCULAR DISEASE; CHOLINESTERASE ACTIVITY; HYPERGLYCAEMIA; MALATHION; METABOLIC DISORDERS; METABOLIC PARAMETERS; PLASMA TRIGLYCERIDES; TRIGLYCERIDE;

METABOLISM;

ADULT; ALCOHOL; BLOOD; CARDIOVASCULAR DISEASE; DIABETES; ENZYME ACTIVITY; HORMONE; LIPID; MALATHION; METABOLISM; ORGANOPHOSPHATE; POLLUTION EFFECT; POLLUTION EXPOSURE; RODENT;

RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

EID: 59849088743     PISSN: 03043894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2008.07.059     Document Type: Article

References (47)

1. Galloway T., and Handy R. Immunotoxicity of organophosphorous pesticides. Ecotoxicology 12 (2003) 345-363
2. Sultatos L.G. Mammalian toxicology of organophosphorous pesticides. J. Toxicol. Environ. Health 43 (1994) 271-289
3. Ecobichon D.J. Toxic effects of pesticides. In: Klaassen C.D. (Ed). Cassarett and Doull's Toxicology. 6th ed. (1996), McGraw-Hill 763-810
4. Abdollahi M., Jalali N., Sabzevari O., Nikfar S., and Fallahpour M. Pesticide poisoning during an 18-month period (1995-1997) in Tehran, Iran. Iran. J. Med. Sci. 24 (1999) 77-81
5. Hagar H.H., and Fahmy A.H. A biochemical, histochemical and ultrasturctural evaluation of the effect of dimethoate intoxication on rat pancreas. Toxicol. Lett. 133 (2002) 161-170
6. Seifert J. Toxicological significance of the hyperglycemia caused by organophosphorous insecticides. Bull. Environ. Contamin. Toxicol. 67 (2001) 463-469
7. Shobba T.R., and Prakash O. Glycosuria in organophosphate and carbamate poisoning. J. Assoc. Phys. India 48 (2000) 1197-1199
8. Maroni M., Colosio C., Ferioli A., and Fait A. Biological monitoring of pesticide exposure: a review. Introduction. Toxicology 7 (2000) 1-118
9. Hazarika A., Sarkar S.N., Hajare S., Katarina M., and Malik J.K. Influence of malathion pretreatment on the toxicity of anilofos in male rats: a biochemical interaction study. Toxicology 185 (2003) 1-8
10. Desi I., Nagymajteny L., Papp A., and Schulz H. Experimental model studies of pesticide exposure. Neurotoxicology 19 4/5 (1998) 611-616
11. Possamai F.P., Fortunato J.J., Feier G., Agostinho F.R., Quevedo J., Wilhelm Filho D., and Dal-Pizzol F. Oxidative stress after acute and sub-chronic malathion intoxication in Wistar rats. Environ. Toxicol. Pharmacol. 23 (2006) 198-204
12. Pournourmohammadi S., Ostad S.N., Azizi E., Hossein Ghahremani M., Farzami B., Minaie B., Larijani B., and Abdollahi M. Induction of insulin resistance by malathion; evidence for disturbed islets cells metabolism and mitochondrial dysfunction. Pest. Biochem. Physiol. 88 (2007) 346-352
13. Garcia-Repetto R., Martinez D., and Repetto M. Malathion and dichlorvos toxicokinetics after the oral administration of malathion and trichlorfon. Vet. Hum. Toxicol. 37a (1995) 306-309
14. Yang M.C., McLean A.J., Rivory L.P., and Le Couteur D.G. Hepatic disposition of neurotoxins and pesticides. Pharmacol. Toxicol. 87 (2000) 286-291
15. Patsch J.R., Prasad S., Gotto A.M., and Patsch W. High density lipoprotein 2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J. Clin. Invest. 80 (1987) 341-347
16. Thompson G.R. Primary hyperlipidemia. Br. Med. Bull. 46 (1990) 986-1004
17. Chobanian A.V. Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist. Hypertension 18 (1991) 130-131
18. Lott J.A., and Turner K. Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin. Chem. 21 (1975) 1754-1760
19. Good C.A., Krames H., and Somogyi M. Chemical procedures for analysis of polysaccharides. Method Enzymol. VII (1933) 34
20. Wilson D.E., and Spiger M.J. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J. Lab. Clin. Med. 82 (1973) 473-482
21. Reaven G.M. Importance of identifying the overweight patient who will benefit the most by losing weight. Ann. Intern. Med. 138 (2003) 420-423
22. Ellman G.L., Courtney K.D., Anders V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
24. Rahimi R., and Abdollahi M. A review on the mechanisms involved in hyperglycemia induced by organophosphorus pesticides. Pest. Biochem. Physiol. 88 2 (2006) 115-121
25. Rodriques M.R., Puga F.R., Chenker E., and Mazanti M.T. Short term effect of malathion on rats' blood glucose and glucose utilization by mammalian cells in vitro. Ecotoxicol. Environ. Saf. 12 (1986) 110-113
26. Abdollahi M., Donyavi M., Pournourmohammadi S., and Saadat M. Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in rats following subchronic exposure to malathion. Comp. Biochem. Physiol. C 137 (2004) 343-347
27. Basiri S., Esmaily H., Vosough-Ghanbari S., Mohammadirad A., Yasa N., and Abdollahi M. Improvement by Satureja khuzestanica essential oil of malathion-induced red blood cells acetylcholinesterase inhibition and altered hepatic mitochondrial glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities. Pest. Biochem. Physiol. 89 (2007) 124-129
28. Abdollahi M., Chan T.S., Subrahmanyam V., and O'Brien P.J. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol. Cell Biochem. 252 (2003) 205-211
29. Davies G.F., Khandelwal R.L., Wu L., Juurlink B.H., and Roesler W.J. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptorgamma (PPARgamma)-independent, antioxidantrelated mechanism. Biochem. Pharmacol. 62 (2001) 1071-1079
30. Rothman D.L., Magnusson I., Cline G., Gerard D., Kahn C.R., Shulman R.G., and Shulman G.I. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulindependent diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 983-987
31. Khanna A.K., Rizvi F., and Chander R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J. Ethnopharmacol. 82 (2002) 19-22
32. Hokanson J.E., and Austin M.A. Plasma triglyceride level is a risk factor to cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based prospective studies. J. Cardiovasc. Risk 3 (1996) 213-219
33. Taskinen M.R. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 (1992) 12-17
34. Austin M.A., Hokanson J.E., and Brunzell J.D. Characterization of low density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr. Opin. Lipidol. 5 (1994) 395-403
35. Vergès B.L. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab. 25 (1999) 32-40
36. Haffner S.M., Mykkanen L., and Stern M.P. Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17 (1994) 1164-1171
37. Lyons T.J., and Jenkins A.J. Lipoprotein glycation and its metabolic consequences. Curr. Opin. Lipidol. 8 (1997) 174-180
38. Steinberg D., Parthasarathy S., and Carew T.E. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924
39. Kim H.J., and Kurup I.V. Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylation. Metabolism 31 (1982) 348-353
40. Guerci B., Antebi H., and Meyer L. Increased ability of LDL from normolipidemic Type 2 diabetic women to generate peroxides. Clin. Chem. 45 (1999) 1439-1448
41. Ogawa W., and Kasuga M. Insulin signaling and pathophysiology of type 2 diabetes mellitus. Nippon Rinsho 64 (2006) 1381-1389
42. Neves M.M., Moraes S.M., and Lanzoni V.P. Hypoinsulinemia in alcoholics with minimal liver disease. Rev. Assoc. Med. Bras. 46 (2000) 23-29
43. Chahil T.J., and Ginsberg H.N. Diabetic dyslipidemia. Endocrinol. Metab. Clin. North Am. 35 (2006) 491-510
44. Palomo I., Alarcon M., Moore-Carrasco R., and Argiles J.M. Hemostasis alterations in metabolic syndrome (review). Int. J. Mol. Med. 18 (2006) 969-974
45. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann. Med. 37 (2005) 347-356
46. Nordlie R.C., Foster J.D., and Lange A.J. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19 (1999) 379-406
47. Taskinen M.R., Beltz W.F., and Harper I. The effects of non insulin-dependent diabetes mellitus on VLDL triglyceride and VLDL apo B metabolism: studies before and after sulfonylurea therapy. Diabetes 35 (1986) 1268-1277